|
|
Volumn 34, Issue 5, 2002, Pages 1591-1593
|
|
Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results
a,b,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
CORTICOSTEROID;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
DRUG DERIVATIVE;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID;
ADULT;
ALOPECIA;
BENELUX;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DIABETES MELLITUS;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FOLLOW UP;
GRAFT FAILURE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
POLYRADICULITIS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL SIGNIFICANCE;
SURVIVAL RATE;
TREATMENT OUTCOME;
ARTICLE;
BELGIUM;
COMPARATIVE STUDY;
DONOR;
FEMALE;
IMMUNOLOGY;
KIDNEY TRANSPLANTATION;
LUXEMBOURG;
MALE;
MIDDLE AGED;
MORTALITY;
PHYSIOLOGY;
STATISTICS;
TIME;
BELGIUM;
COMPARATIVE STUDY;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LUXEMBOURG;
MALE;
MIDDLE AGE;
MYCOPHENOLIC ACID;
SURVIVAL RATE;
TACROLIMUS;
TIME FACTORS;
TISSUE DONORS;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035993660
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03035-X Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (4)
|
